CAP Publishes Recommendations for Prostate Cancer Active Surveillance
An international multispecialty team offers guidance on eligibility for active surveillance, providing low-risk prostate cancer patients a less-harmful treatment option.
Read MorePosted by Steve Halasey | Sep 5, 2014 | Research |
An international multispecialty team offers guidance on eligibility for active surveillance, providing low-risk prostate cancer patients a less-harmful treatment option.
Read MorePosted by Steve Halasey | Aug 25, 2014 | Cancer |
CAP ’14, the College of American Pathologists annual meeting, September 7–10, will feature advances in molecular medicine, genetic testing, and laboratory technologies.
Read MorePosted by Jenny Lower | Jul 30, 2014 | Cancer, Heart Disease, Osteoporosis, Womens Health |
When it comes to women’s health, molecular diagnostics are playing a bigger role than ever before in uncovering how sex differences are expressed in cancer.
Read MorePosted by Steve Halasey | Jul 15, 2014 | Cancer |
bioMerieux sepsis facility expansion will help address the global public health threat of sepsis and meet the related demand for microbial detection.
Read MorePosted by Steve Halasey | Jun 30, 2014 | Cancer, Molecular Diagnostics, Prostate |
The US Patent and Trademark Office has issued a notice of allowance to Rosetta Genomics for its patent application covering compositions and methods for prognosis and treatment of prostate cancer.
Read More